Krensavage Asset Management, LLC Q3 2025 Filing

Filed November 17, 2025

Portfolio Value

$234.7M

Holdings

17

Report Date

Q3 2025

Filing Type

13F-HR

All Holdings (17 positions)

#StockSharesValue% PortfolioType
1
UTHUNITED THERAPEUTICS CORP
97,646$40.9M17.44%
2
ENTAENANTA PHARMACEUTICALS INC
2,114,444$25.3M10.78%
3
JAZZJAZZ PHARMACEUTICALS PLC
167,816$22.1M9.42%
4
BMRNBIOMARIN PHARMACEUTICAL INC
405,450$22.0M9.36%
5
EX9EXELIXIS INC
518,526$21.4M9.12%
6
SUPNSUPERNUS PHARMACEUTICALS INC
363,479$17.4M7.40%
7
SNYSANOFI-ADR
323,946$15.3M6.51%
8
AVDLAVADEL PHARMACEUTICALS
955,860$14.6M6.22%
9
GSKGSK PLC-SPON ADR
271,729$11.7M5.00%
10
CAHCARDINAL HEALTH INC
73,745$11.6M4.93%
11
INDIVIOR PLC
339,532$8.2M3.49%
12
BNTXBIONTECH SE-ADR
79,366$7.8M3.33%
13
ALKSALKERMES PLC
207,822$6.2M2.66%
14
VNDAVANDA PHARMACEUTICALS INC
1,180,388$5.9M2.51%
15
REGNREGENERON PHARMACEUTICALS
4,000$2.2M0.96%
16
BIIBBIOGEN INC
10,000$1.4M0.60%
17
EOLSEVOLUS INC
100,000$614K0.26%